Clinical Trial Update: Scalable Behavioral Program for Weight Loss Maintenance After GLP-1 and Anti-Obesity Medication Discontinuation [NA]

View source ↗

Summary

A clinical trial update describes a scalable behavioral program to help maintain weight loss after discontinuation of GLP-1 and anti-obesity medications. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Weight Loss, GLP - 1 | NA | Status: NOT_YET_RECRUITING